These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30386649)

  • 1. Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer?
    Dangi AD; Kumar RM; Kodiatte TA; Gowri M; Kumar S; Devasia A; Kekre N
    Cent European J Urol; 2018; 71(3):287-294. PubMed ID: 30386649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
    Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study.
    Ali-el-Dein B; Nabeeh A; el-Baz M; Shamaa S; Ashamallah A
    Br J Urol; 1997 May; 79(5):731-5. PubMed ID: 9158511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy in different risk-groups of patients with superficial bladder cancer.
    Startsev V; Pouline I
    Arch Ital Urol Androl; 2005 Jun; 77(2):93-8. PubMed ID: 16146269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of separate tumor base biopsy in transurethral resection of bladder tumors.
    Sionov BV; Tsivian M; Taha T; Bass R; Kheifets A; Sidi AA; Tsivian A
    Cent European J Urol; 2020; 73(4):440-444. PubMed ID: 33552569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center.
    Bhirud DP; Mittal A; Kumar S; Narain TA; Kishore S; Navriya SC; Ranjan SK; Panwar VK
    Indian J Surg Oncol; 2022 Sep; 13(3):604-611. PubMed ID: 36187522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
    Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
    Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
    Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
    Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study.
    Zhang Y; Xie L; Chen T; Xie W; Wu Z; Xu H; Xing C; Sha N; Shen Z; Qie Y; Liu X; Hu H; Wu C
    Onco Targets Ther; 2016; 9():605-11. PubMed ID: 26869805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of reTURB for pTa high grade bladder urothelial carcinoma].
    Branchu B; Léon P; Jeglinschi SC; Durlach A; Trigui S; Birembaut P; Larré S
    Prog Urol; 2020 Jan; 30(1):19-25. PubMed ID: 31866142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer.
    Gill TS; Das RK; Basu S; Dey RK; Mitra S
    Urol Ann; 2014 Oct; 6(4):305-8. PubMed ID: 25371606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
    Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
    Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
    Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B
    Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of restage transurethral resection of bladder tumor.
    Manoharan V; Mavuduru RS; Kumar S; Kakkar N; Devana SK; Bora GS; Singh SK; Mandal AK
    Indian J Urol; 2018; 34(4):273-277. PubMed ID: 30337782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
    Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
    J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
    Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
    Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.